Document is current
Any future updates will be listed below
-
Authors
Hrubša, Marcel
Konečný, Lukáš
Sirová, Michaela
Homolková, Slávka
Carazo, Alejandro
Matoušová, Kateřina
Krčmová, Lenka Kujovská
Bernhauerová, Veronika
Blaha, Vladimír
Šmahelová, Alena
Mladěnka, Přemysl https://orcid.org/0000-0002-6076-6900
-
Funding
Funding for this research was provided by:
Univerzita Karlova v Praze (260 663)
MH CZ - DRO (UHHK, 00179906)
Agentura Pro Zdravotnický Výzkum České Republiky (NU21-02-00135)
European Union (CZ.02.01.01/00/22_008/0004607)
- License Information
-
More Information
Article History
Received: 2 February 2026
Accepted: 30 June 2026
First Online: 17 July 2026
Declarations
Ethics approval and consent to participate: The study was done in accordance with the Declaration of Helsinki, and approval was obtained from the Research ethics committee, Faculty of Pharmacy in Hradec Králové, Charles University (No. UKFaF/92240/2021–2 from March 3, 2021) and the Ethics committee of the University Hospital in Hradec Králové (No. 202207 IO4 from 1 July 2022) before the start of the study, which ran from October 5, 2022 to December 10, 2024. Informed consent was obtained from each patient. In addition to a signed informed consent, relevant patient data (age, weight, height, smoking status, diagnoses, and medication) were recorded and anonymized.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
